The fate of dozens of cases against the makers of an allegedly defective hip replacement depends on the outcome of a court hearing today. Three judges(...)

US doctors and teaching hospitals got $6.49 billion from drug and medical-device makers in 2014, according to new government data .

US doctors and teaching hospitals got $6.49 billion from drug and medical-device makers in 2014, according to new government data on the financial lin(...)

Johnson & Johnson Vision Care is to invest over € 100 million in an expansion of its manufacturing operations at its site in Limerick.

Johnson & Johnson Vision Care is to invest over € 100 million in an expansion of its manufacturing operations at its site in the National Technol(...)

Attendees at the “Limerick for IT” event try out some cool technologies, including the Oculus Rift virtual reality 3D Headset system.

The University of Limerick (UL) has been collaborating with industry, other education providers, and local authorities to help provide the skills requ(...)

Block 8, Brookfield Hall Student Village, University of Limerick: 29 two-bedroom apartments, comprising eight three-bedroom units and three four-bedroom homes

A block of 40 apartments in Brookfield Hall Student Village close to the University of Limerick is to be offered for sale at a knockdown price of €1.7(...)

Last quarter Johnson & Johnson was the first of many drugmakers to report lower-than-expected guidance or sales declines due to the US currency’s gain

Johnson & Johnson, the world’s biggest maker of healthcare products, reported quarterly earnings that topped analysts’ estimates as new cancer and(...)

Dr Mary Shire, vice president research, University of Limerick. Photograph:  Sean Curtin

The University of Limerick (UL) has a long track-record of excellence in manufacturing industry collaboration. This is reflected in its success in est(...)

The acquisition is the latest in a spate of big pharma deals this year as many companies are strengthening their portfolios as old drugs go generic

AbbVie is to buy Pharmacyclics for about $21 billion, giving it access to what is expected to be one of the world’s top-selling cancer drugs and expan(...)

Pfizer has offered $90 per share in cash for Hospira Photograph: Reuters

Pharmaceutical giant Pfizer has offered to buy Hospira for about $15 billion (€13bn) to boost its portfolio of generic injectible drugs and biosimilar(...)

Gerard Whelan, managing director of Brandcentral

What is unique about your business? My international experience. I’ve done a lot of work in Scandinavia and a global project for Johnson & Johnson(...)